Search hospitals
>
Ohio
>
Columbus
Ohio State University
Claim this profile
Columbus, Ohio 43210
Global Leader in Heart Failure
Global Leader in Cancer
Conducts research for Breast Cancer
Conducts research for Stroke
Conducts research for Lung Cancer
1255 reported clinical trials
214 medical researchers
Summary
Ohio State University is a medical facility located in Columbus, Ohio. This center is recognized for care of Heart Failure, Cancer, Breast Cancer, Stroke, Lung Cancer and other specialties. Ohio State University is involved with conducting 1,255 clinical trials across 2,083 conditions. There are 214 research doctors associated with this hospital, such as Floor Backes, MD, Alice Mims, Uma Borate, MD, and Michael V Knopp, MD, PhD.
Area of expertise
Heart Failure
Ohio State University has run 121 trials for Heart Failure. Some of their research focus areas include:
Cancer
Ohio State University has run 109 trials for Cancer. Some of their research focus areas include:
Top PIs
Floor Backes, MD
Ohio State University Comprehensive Cancer Center
3 years of reported clinical research
Alice Mims
Ohio State University Comprehensive Cancer Center
6 years of reported clinical research
Uma Borate, MD
Ohio State University Comprehensive Cancer Center
4 years of reported clinical research
Michael V Knopp, MD, PhD
The Ohio State University Wexner Medical Center
3 years of reported clinical research
Clinical Trials running at Ohio State University
Stroke
Melanoma
Cancer
Lung Cancer
Facioscapulohumeral muscular dystrophy
Skin Cancer
Alzheimer's Disease
Atrial Fibrillation
Facioscapulohumeral Muscular Dystrophy
Age-Related Macular Degeneration
Low-Dose Colchicine
for Peripheral Artery Disease
The Low dose ColchicinE in pAtients with peripheral Artery DiseasE to address residual vascular Risk (LEADER-PAD) trial will evaluate if anti-inflammatory therapy with colchicine will reduce vascular events in patients with symptomatic peripheral artery disease.
Recruiting
3 awards
Phase 3
3 criteria
Sovateltide
for Stroke
Extensive research is being conducted in search of neuroprotective agents for possible use in the acute phase of stroke and agents that can be used for neurorepair in later stages of stroke. Several trials have been conducted and are in progress using different pharmacological agents, but none of the studies involve the stimulation of ETB receptors to treat cerebral ischemic stroke. Sovateltide (IRL-1620, PMZ-1620) has been effective in animal models of cerebral ischemic stroke. Its safety and tolerability have been demonstrated in a human phase I study with 7 subjects. Clinical phase II and III results indicate that sovateltide is a novel, first-in-class, highly effective drug candidate for treating cerebral ischemic stroke. Safety and significant efficacy in improving the National Institutes of Health Stroke Scale (NIHSS), Modified Rankin scale (mRS), and Barthel index (BI) obtained in phase II and III studies in patients with cerebral ischemic stroke in India are convincing and encouraged us to investigate its safety and efficacy in cerebral ischemic stroke patients in the United States. Therefore, the plan is to conduct a phase III clinical study to evaluate the safety and efficacy of sovateltide therapy along with standard of care in patients of acute ischemic stroke.
Recruiting
2 awards
Phase 3
3 criteria
Anticoagulation + Antiplatelet Therapy
for Post-Operative Atrial Fibrillation
The primary objective of this study is to evaluate the effectiveness (prevention of thromboembolic events) and safety (major bleeding) of adding oral anticoagulation (OAC) to background antiplatelet therapy in patients who develop new-onset post-operative atrial fibrillation (POAF) after isolated coronary artery bypass graft (CABG) surgery. All patients with a qualifying POAF event, who decline randomization, will be offered the option of enrollment in a parallel registry that captures their baseline risk profile and their treatment strategy in terms of anticoagulants or antiplatelets received. These patients will also be asked to fill out a brief decliner survey.
Recruiting
2 awards
Phase 3
2 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Ohio State University?
Ohio State University is a medical facility located in Columbus, Ohio. This center is recognized for care of Heart Failure, Cancer, Breast Cancer, Stroke, Lung Cancer and other specialties. Ohio State University is involved with conducting 1,255 clinical trials across 2,083 conditions. There are 214 research doctors associated with this hospital, such as Floor Backes, MD, Alice Mims, Uma Borate, MD, and Michael V Knopp, MD, PhD.
Where is Ohio State University located?
To reach Ohio State University Hospital in Columbus, OH, navigate to Medical Center Drive, continue past the intersection of Medical Center and 9th Avenue straight to University Hospital (Rhodes Hall) or Ross Heart Hospital. Use the Patient Valet on your right for parking. For convenience, consider using real-time driving directions from Waze to account for live traffic updates and road conditions.
Who should I call to ask about financial aid or insurance network?
For financial assistance at Ohio State University Wexner Medical Center: - Contact the financial counseling team at 614-293-0860, option 2. - For the Medication Assistance Program, call 614-293-3868. - For insurance inquiries, billing, and financial assistance questions, call 1-800-678-8037 or 614-293-2100. - General inquiries: OSUCareConnection@osumc.edu - Website-related issues: webmaster@osumc.edu
What insurance does Ohio State University accept?
The Ohio State University Wexner Medical Center accepts a wide range of insurance plans. This includes commercial plans like Aetna and Anthem; government programs such as the Breast and Cervical Cancer Project (BCCP), Medicaid (AmeriHealth Caritas), and Medicare; marketplace plans like Buckeye Ambetter, CareSource Marketplace, and Molina Healthcare of Ohio; and Medicaid plans including AmeriHealth Caritas, Buckeye Community Health Plan, CareSource, Humana Healthy Horizons, Medicaid Ohio Traditional, Molina Healthcare of Ohio, and UnitedHealthcare Community Plan. They also accept traditional Medicare plans and Medicare Plans with Medigap coverage, along with other government plans like TriCare.
What awards or recognition has Ohio State University received?
Ohio State University Hospital, located in Columbus, Ohio, is ranked #28 by U.S. News & World Report as a top research institution and #40 in NIH research funding, with over $367M in total funding. The hospital is actively involved in more than 2,000 research studies and clinical trials, highlighting its strong commitment to research excellence and support for researchers.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.